Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.04%

Investing.com – Denmark stocks were lower after the close on Wednesday, as losses in the , and sectors led shares lower.

At the close in Copenhagen, the declined 0.04%.

The best performers of the session on the were Pandora A/S (CSE:), which rose 16.09% or 46.5 points to trade at 335.5 at the close. Meanwhile, Novozymes A/S B (CSE:) added 4.93% or 14.3 points to end at 304.3 and ISS A/S (CSE:) was up 2.35% or 3.95 points to 172.00 in late trade.

The worst performers of the session were Coloplast A/S (CSE:), which fell 2.35% or 19.0 points to trade at 790.0 at the close. Genmab (CSE:) declined 1.64% or 23.5 points to end at 1406.5 and Carlsberg A/S B (CSE:) was down 1.60% or 15.8 points to 970.2.

Rising stocks outnumbered declining ones on the Copenhagen Stock Exchange by 60 to 58 and 18 ended unchanged.

Crude oil for December delivery was up 1.52% or 0.83 to $55.31 a barrel. Elsewhere in commodities trading, Brent oil for delivery in December rose 1.31% or 0.78 to hit $60.48 a barrel, while the December Gold Futures contract rose 0.61% or 9.05 to trade at $1496.55 a troy ounce.

USD/DKK was up 0.06% to 6.7191, while EUR/DKK rose 0.01% to 7.4706.

The US Dollar Index Futures was up 0.08% at 97.333.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.